US Patent 11407838 Erenumab compositions and uses thereof
Patent 11407838 was granted and assigned to Amgen on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Jose Gregorio Ramirez0
Kenneth Lawson0
Noel Rieder0
Suminda Hapuarachchi0
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114078380
Date of Patent
August 9, 2022
0Patent Application Number
163722910
Date Filed
April 1, 2019
0Patent Primary Examiner
Edits on 4 Apr, 2023
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Edits on 10 Aug, 2022
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+332 characters)
US Patent 11407838 Erenumab compositions and uses thereof
Article
The present invention relates to compositions comprising erenumab and one or more erenumab variants, including isomerization variants, deamidation variants, acidic variants, and HMW species. Pharmaceutical formulations comprising the erenumab compositions and methods of using and characterizing the compositions are also described.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11407838
Date of patent
August 9, 2022
Patent application number
16372291
Date Filed
April 1, 2019
Patent primary examiner
Find more entities like US Patent 11407838 Erenumab compositions and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
